肿瘤假体置换术后相关并发症分析
Analysis of Tumor Prosthesis Arthroplasty Complications

作者: 黄俊琪 * , 毕文志 :中国人民解放军总医院骨科,北京;

关键词: 关节置换骨肿瘤并发症翻修术Arthroplasty Bone Neoplasms Complication Revision

摘要:
肿瘤假体置换术是侵袭性或恶性肿瘤切除术后主要的重建方式。综合治疗对骨肿瘤良好控制的前提下,肿瘤假体置换保留了患者肢体和部分功能,提高其生活质量。随着假体使用的广泛,长期随访中其并发症报道逐渐增多。通过对文献回顾性研究,将并发症主要分为两种类型,即肿瘤相关和非肿瘤相关并发症。本研究旨在对并发症进行分析研究。

Abstract: Tumor prosthesis applies to reconstruction after invasive or malignant neoplasm’s resection. Multidiscipline treatment is known to local and system control. The desirable limb-saving condi-tion leads to more patients undergoing arthroplasty. The use of tumor prosthesis is accessible because of high survival rate. The complications of arthroplasty attach growing attention in the long- term follow-up. There are two types of failure in the retrospective study, tumor-related and non- tumor-related complications. This study is aimed to classify complications and summarize diagnosis and treatment.

文章引用: 黄俊琪 , 毕文志 (2017) 肿瘤假体置换术后相关并发症分析。 世界肿瘤研究, 7, 21-27. doi: 10.12677/WJCR.2017.72004

参考文献

[1] Anderson, M.E. (2016) Update on Survival in Osteosarcoma. Orthopedic Clinics of North America, 47, 283-292.
https://doi.org/10.1016/j.ocl.2015.08.022

[2] Ferrari, S. and Serra, M. (2015) An Update on Chemotherapy for Osteosarcoma. Expert Opinion on Pharmacotherapy, 16, 2727-2736.
https://doi.org/10.1517/14656566.2015.1102226

[3] Lopresti, M., Rancati, J., Farina, E., et al. (2015) Rehabilitation Pathway after Knee Arthroplasty with Mega Prosthesis in Osteosarcoma. Recenti Progressi in Medicina, 106, 385-392.

[4] Li, D., Ma, H., Zhang, W., et al. (2015) Analysis of Implant-Related Complications after Hinge Knee Replacement for Tumors around the Knee. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 29, 936-940.

[5] Houdek, M.T., Wagner, E.R., Wilke, B.K., et al. (2016) Long Term Outcomes of Cemented Endoprosthetic Reconstruction for Periarticular Tumors of the Distal Femur. Knee, 23, 167-172.
https://doi.org/10.1016/j.knee.2015.08.010

[6] Bacci, G., Forni, C., Longhi, A., et al. (2007) Local Recurrence and Local Control of Non-Metastatic Osteosarcoma of the Extremities: A 27-Year Experience in a Single Institution. Journal of Surgical Oncology, 96, 118-123.
https://doi.org/10.1002/jso.20628

[7] Palmerini, E., Jones, R.L., Marchesi, E., et al. (2016) Gemcitabine and Docetaxel in Relapsed and Unresectable High-Grade Osteosarcoma and Spindle Cell Sarcoma of Bone. BMC Cancer, 16, 280.
https://doi.org/10.1186/s12885-016-2312-3

[8] The ESMO/European Sarcoma Network Working Group (2014) Bone Sarcomas: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Annals of Oncology, 25, iii113-iii123.
https://doi.org/10.1093/annonc/mdu256

[9] Rothermundt, C., Seddon, B.M., Dileo, P., et al. (2016) Follow-up Practices for High-Grade Extremity Osteosarcoma. BMC Cancer, 16, 301.
https://doi.org/10.1186/s12885-016-2333-y

[10] Kang, X., Huang, Z., Shi, A., et al. (2016) Deficiencies in the Diagnosis and Treatment of Pulmonary Metastatic Osteosarcoma: A Chinese Multidisciplinary Survey. Zhongguo Fei Ai Za Zhi, 19, 153-160.

[11] Puri, A., Gulia, A., Hawaldar, R., et al. (2014) Does Intensity of Surveillance Affect Survival after Surgery for Sarcomas? Results of a Randomized Noninferiority Trial. Clinical Orthopaedics and Related Research, 472, 1568-1575.
https://doi.org/10.1007/s11999-013-3385-9

[12] Chou, A.J., Gupta, R., Bell, M.D., et al. (2013) Inhaled Lipid Cisplatin (ILC) in the Treatment of Patients with Relapsed/Progressive Osteosarcoma Metastatic to the Lung. Pediatric Blood & Cancer, 60, 580-586.
https://doi.org/10.1002/pbc.24438

[13] Yu, L., Cai, L., Hu, H., et al. (2014) Experiments and Synthesis of Bone-Targeting Epirubicin with the Water-Soluble Macromolecular Drug Delivery Systems of Oxidized-Dextran. Journal of Drug Targeting, 22, 343-351.
https://doi.org/10.3109/1061186X.2013.877467

[14] Gosiengfiao, Y., Reichek, J., Woodman, J., et al. (2012) Gemcitabine with or without Docetaxel and Resection for Recurrent Osteosarcoma: The Experience at Children’s Memorial Hospital. Journal of Pediatric Hematology/Oncology, 34, e63-e65.

[15] Machak, G.N., Polotskiĭ, B.E., Meluzova, O.M., et al. (2010) Treatment of Relapsed Osteosarcoma. Role of Chemotherapy Using Ifosamide and Carboplatin. Voprosy Onkologii, 56, 220-225.

[16] Dinçbaş, F.O., Koca, S., Mandel, N.M., et al. (2005) The Role of Preoperative Radiotherapy in nonmetAstatic High-Grade Osteosarcoma of the Extremities for Limb-Sparing Surgery. International Journal of Radiation Oncology*Biology*Physics, 62, 820-828.
https://doi.org/10.1016/j.ijrobp.2004.11.006

[17] Fagioli, F., Aglietta, M., Tienghi, A., Ferrari, S., et al. (2002) High-Dose Chemotherapy in the Treatment of Relapsed Osteosarcoma: An Italian Sarcoma Group Study. Journal of Clinical Oncology, 20, 2150-2156.
https://doi.org/10.1200/JCO.2002.08.081

[18] Kushnir, I., Kolander, Y., Bickels, J., et al. (2014) Is It Important to Maintain High-Dose Intensity Chemotherapy in the Treatment of Adults with Osteosarcoma. Medical Oncology, 31, 936.
https://doi.org/10.1007/s12032-014-0936-1

[19] Wirganowicz, P.Z., Eckardt, J.J., Dorey, F.J., et al. (1999) Etiology and Results of Tumor Endoprosthesis Revision Surgery in 64 Patients. Clinical Orthopaedics and Related Research, 358, 64-74.

[20] Hardes, J., Ahrens, H., Gosheger, G., et al. (2014) Management of Complications in Megaprostheses. Der Unfallchirurg, 117, 607-613.
https://doi.org/10.1007/s00113-013-2477-z

[21] Pajarinen, J., Lin, T.H., Nabeshima, A., et al. (2016) Mesenchymal Stem Cells in the Aseptic Loosening of Total Joint Replacements. Journal of Biomedical Materials Research Part A, 105, 1195-1207.

[22] Maloney, W.J. and Smith, R.L. (1996) Periprosthetic Osteolysis in Total Hip Arthroplasty: The Role of Particulate Wear Debris. Instructional Course Lectures, 45, 171-182.

[23] Kempthorne, J.T., Ailabouni, R., Raniga, S., Hammer, D. and Hooper, G. (2015) Occult Infection in Aseptic Joint Loosening and the Diagnostic Role of Implant Sonication. BioMed Research International, 2015, Article ID: 946215.
https://doi.org/10.1155/2015/946215

[24] Aibinder, W.R., Schoch, B., Schleck, C., et al. (2017) Revisions for Aseptic Glenoid Component Loosening after Anatomic Shoulder Arthroplasty. Journal of Shoulder and Elbow Surgery, 26, 443-449.

[25] Jeys, L.M., Kulkarni, A., Grimer, R.J., et al. (2008) Endoprosthetic Reconstruction for the Treatment of Musculoskeletal Tumors of the Appendicular Skeleton and Pelvis. The Journal of Bone and Joint Surgery-America Volume, 90, 1265-1271.
https://doi.org/10.2106/JBJS.F.01324

[26] Myers, G.J., Abudu, A.T., Carter, S.R., et al. (2007) Endoprosthetic Replacement of the Distal Femur for Bone Tumours: Long-Term Results. The Journal of Bone and Joint Surgery-British Volume, 89, 521-526.
https://doi.org/10.1302/0301-620X.89B4.18631

[27] Dowsey, M.M. and Choong, P.F. (2008) Obesity Is a Major Risk Factor for Prosthetic Infection after Primary Hip Arthroplasty. Clinical Orthopaedics and Related Research, 466, 153-158.
https://doi.org/10.1007/s11999-007-0016-3

[28] Morii, T., Yabe, H., Morioka, H., et al. (2010) Postoperative Deep Infection in Tumor Endoprosthesis Reconstruction around the Knee. Journal of Orthopaedic Science, 15, 331-339.
https://doi.org/10.1007/s00776-010-1467-z

[29] McDonald, M., Grabsch, E., Marshall, C., et al. (1998) A Single- versus Multiple-Dose Antimicrobial Prophylaxis for Major Surgery: A Systematic Review. ANZ Journal of Surgery, 68, 388-396.
https://doi.org/10.1111/j.1445-2197.1998.tb04785.x

[30] Peel, T., May, D., Buising, K., et al. (2014) Infective Complications Following Tumour Endoprosthesis Surgery for Bone and Soft Tissue Tumours. European Journal of Surgical Oncology, 40, 1087-1094.

[31] Juul, R., Fabrin, J., Poulsen, K., et al. (2016) Use of a New Knee Prosthesis as an Articulating Spacer in Two-Stage Revision of Infected Total Knee Arthroplasty. Knee Surgery & Related Research, 28, 239-244.
https://doi.org/10.5792/ksrr.2016.28.3.239

[32] Ehlinger, M., Adam, P., Di Marco, A., et al. (2011) Periprosthetic Femoral Fractures Treated by Locked Plating: Feasibility Assessment of the Mini-Invasive Surgical Option. A Prospective Series of 36 Fractures. Orthopaedics & Traumatology: Surgery & Research, 97, 622-628.
https://doi.org/10.1016/j.otsr.2011.01.017

[33] Giesinger, K., Ebneter, L., Day, R.E., et al. (2014) Can Plate Osteosynthesis of Periprosthethic Femoral Fractures Cause Cement Mantle Failure around a Stable Hip Stem? A Biomechanical Analysis. The Journal of Arthroplasty, 29, 1308-1312.
https://doi.org/10.1016/j.arth.2013.12.015

[34] Rorabeck, C.H. and Taylor, J.W. (1999) Periprosthetic Fractures of the Femur Complicating Total Knee Arthroplasty. Orthopedic Clinics of North America, 30, 265-277.

[35] Jentzsch, T., Erschbamer, M., Seeli, F., et al. (2013) Extensor Function after Medial Gastrocnemius Flap Reconstruction of the Proximal Tibia. Clinical Orthopaedics and Related Research, 471, 2333-2339.
https://doi.org/10.1007/s11999-013-2851-8

[36] Althausen, P.L., Lee, M.A., Finkemeier, C.G., et al. (2003) Operative Stabilization of Supracondylar Femur Fractures above Total Knee Arthroplasty: A Comparison of Four Treatment Methods. The Journal of Arthroplasty, 18, 834-839.
https://doi.org/10.1016/S0883-5403(03)00339-5

[37] Gosheger, G., Gebert, C., Ahrens, H., et al. (2006) Endoprosthetic Reconstruction in 250 Patients with Sarcoma. Clinical Orthopaedics and Related Research, 450, 164-171.

[38] Dobbs, R.E., Hanssen, A.D., Lewallen, D.G. and Pagnano, M.W. (2005) Quadriceps Tendon Rupture after Total Knee Arthroplasty. Prevalence, Complications, and Outcomes. The Journal of Bone and Joint Surgery-America Volume, 87, 37-45.

分享
Top